Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03547518 · ClinicalTrials.gov registry record · NA
Sham Controlled Trial of Rapid Induction Percutaneous Tibial Nerve Stimulation
A NA study, sponsored by Corewell Health East.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT03547518: Completed NA study, sponsored by Corewell Health East.
NCT03547518 is a NA study that has completed, run by Corewell Health East. The registered enrollment target is 25 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03547518, a NA study, has completed, sponsored by Corewell Health East.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
The aim of this study is to determine the efficacy of an accelerated course for percutaneous tibial nerve stimulation (PTNS) induction to treat overactive bladder symptoms. The standard 12 weekly induction treatments may be a patient burden and a more rapid induction may speed up symptomatic improvement.
Primary Outcome
Number of subjects reporting "Moderately" or "Markedly Improved" responses on the GRA after 3 interventions
Interventions
- DEVICE Sham treatment
- DEVICE PTNS treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2018-03-13 |
| Est. Completion | 2022-11-17 |
| Phase | NA |
What the finished NCT03547518 record still lists
NCT03547518 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Sham treatment is the first listed.
NCT03547518 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03547518 about?
NCT03547518 is a clinical study titled "Sham Controlled Trial of Rapid Induction Percutaneous Tibial Nerve Stimulation". The aim of this study is to determine the efficacy of an accelerated course for percutaneous tibial nerve stimulation (PTNS) induction to treat overactive bladder symptoms. The standard 12 weekly induction treatments may be a patient burden and a more rapid induction may speed up symptomatic improve...
What is the current status of trial NCT03547518?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2018-03-13. Estimated completion is 2022-11-17.
What interventions are being tested in trial NCT03547518?
The interventions under investigation include: Sham treatment (DEVICE), PTNS treatment (DEVICE).
Who is sponsoring clinical trial NCT03547518?
This trial is sponsored by Corewell Health East, which has 106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03547518's enrollment target sits among peer trials
25 1712th of 2000 higher than 265 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI